1. Home
  2. VEON vs DAWN Comparison

VEON vs DAWN Comparison

Compare VEON & DAWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VEON Ltd. ADS

VEON

VEON Ltd. ADS

HOLD

Current Price

$51.04

Market Cap

3.5B

ML Signal

HOLD

Logo Day One Biopharmaceuticals Inc.

DAWN

Day One Biopharmaceuticals Inc.

HOLD

Current Price

$8.40

Market Cap

624.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VEON
DAWN
Founded
1992
2018
Country
United Arab Emirates
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.5B
624.8M
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
VEON
DAWN
Price
$51.04
$8.40
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
9
Target Price
$73.25
$26.56
AVG Volume (30 Days)
100.2K
2.6M
Earning Date
11-10-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
8.91
N/A
Revenue
$4,226,000,000.00
$133,672,000.00
Revenue This Year
$10.26
$15.51
Revenue Next Year
$7.61
$49.99
P/E Ratio
$5.74
N/A
Revenue Growth
6.74
31.11
52 Week Low
$34.55
$5.64
52 Week High
$64.00
$13.53

Technical Indicators

Market Signals
Indicator
VEON
DAWN
Relative Strength Index (RSI) 52.08 48.66
Support Level $49.82 $7.90
Resistance Level $51.54 $8.67
Average True Range (ATR) 1.54 0.52
MACD -0.07 -0.09
Stochastic Oscillator 34.84 26.54

Price Performance

Historical Comparison
VEON
DAWN

About VEON VEON Ltd. ADS

VEON Ltd is a United Arab Emirates-based digital operator providing connectivity and Internet services to corporations and individuals. The company offers mobile and fixed-line telecommunications services through a range of traditional and broadband mobile technologies. The company's reportable segments consist of the following five segments: Pakistan, Ukraine, Kazakhstan, Bangladesh, and Uzbekistan. It provides its services under the Beeline, Kyivstar, Banglalink, and Jazz brands. It generates the majority of its revenue from Pakistan.

About DAWN Day One Biopharmaceuticals Inc.

Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, and kinase inhibitor.

Share on Social Networks: